# Alpha‐Fetoprotein Stimulates Cleavage of Membranal MICA/B on Liver Cancer Cell Lead to Escape Immune Surveillance of Natural Killer Cells

**Authors:** Xiaowei Li, Siren Feng, Xueqin Wu, Yinglian Pan, Yuli Zhou, Kun Liu, Bo Lin, Wei Li, Mengsen Li, Mingyue Zhu

PMC · DOI: 10.1111/jcmm.71076 · Journal of Cellular and Molecular Medicine · 2026-02-26

## TL;DR

This study shows how alpha-fetoprotein helps liver cancer cells avoid detection by immune cells, offering new insights into cancer immune evasion.

## Contribution

The paper reveals a novel mechanism by which AFP promotes immune escape in HCC via MICA/B cleavage and MMP9 activation.

## Key findings

- AFP reduces membrane MICA/B levels in HCC cells by upregulating MMP9 through the PI3K/AKT pathway.
- High AFP levels suppress NK-92 cell activity and cytokine release, aiding HCC immune evasion.
- Interfering with AFP reverses its immunosuppressive effects on NK-92 cells.

## Abstract

Hepatocellular carcinoma (HCC) could escape immune surveillance. Alpha‐fetoprotein (AFP) serves as a significant biomarker for HCC; however, its influence on HCC immune surveillance remains elusive. RNA‐Seq data of HCC were obtained from TCGA and GEO databases for the expression of AFP, MICA/B, and related genes. Immunohistochemistry for protein detection in tissues; the expression of target proteins was detected by Western blotting; membrane protein expression and cytotoxicity assessment were analysed by flow cytometry; protein localization was observed by immunofluorescence, cytokine levels were detected by ELISA; mRNA quantification was analysed by qRT‐PCR, cell proliferation was measured by CCK‐8, animal experiments were applied to observe immune response, and cytotoxicity assays were used to evaluate the killing effect of natural killer‐92 (NK‐92) cells. Results indicated that in both databases and patient tissues, AFP and MICA/B were highly expressed in the HCC tissues. AFP inhibits the membrane level of MICA/B in HCC cells and promotes the shedding of MICA/B by upregulating MMP9 expression via activation of the PI3K/AKT signalling pathway. Furthermore, AFP suppressed NK‐92 cells from attacking HCC cells and restricted the release of cytokines by NK‐92 cells, whereas interference with AFP had opposite effects. This finding indicated that AFP stimulated the cleavage of membrane MICA/B in HCC cells, increased the content of soluble MICA/B, and blocked the interaction between MICA/B and NKG2D, which may be involved in the upregulation of MMP9 expression via activation of the PI3K/AKT signalling pathway. These effects inhibited the activation of NK‐92 cells, causing HCC cells to escape attack by NK‐92 cells.

## Linked entities

- **Genes:** AFP (alpha fetoprotein) [NCBI Gene 174], MICB (MHC class I polypeptide-related sequence B) [NCBI Gene 450199], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318]
- **Proteins:** MICB (MHC class I polypeptide-related sequence B), MMP9 (matrix metallopeptidase 9)
- **Diseases:** Hepatocellular carcinoma (MONDO:0007256), HCC (MONDO:0007256)

## Full-text entities

- **Genes:** MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, MMP14 (matrix metallopeptidase 14) [NCBI Gene 4323] {aka MMP-14, MMP-X1, MT-MMP, MT-MMP 1, MT1-MMP, MT1MMP}, KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ADAM17 (ADAM metallopeptidase domain 17) [NCBI Gene 6868] {aka ADAM18, CD156B, CSVP, HYPT16, NISBD, NISBD1}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, MICA (MHC class I polypeptide-related sequence A) [NCBI Gene 100507436] {aka MIC-A, PERB11.1}, MICB (MHC class I polypeptide-related sequence B) [NCBI Gene 4277] {aka PERB11.2}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ADAM10 (ADAM metallopeptidase domain 10) [NCBI Gene 102] {aka AD10, AD18, CD156c, CDw156, HsT18717, MADM}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, Afp (alpha fetoprotein) [NCBI Gene 11576], ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1) [NCBI Gene 476] {aka CMT2DD, HOMGSMR2}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}
- **Diseases:** metastasis (MESH:D009362), chronic viral hepatitis infection (MESH:D014777), sMICA/B (MESH:D008311), Cancer (MESH:D009369), -B (MESH:D006509), NOD (MESH:D020191), Cytotoxicity (MESH:D064420), alcoholic fatty liver (MESH:D005235), metabolic dysfunction-associated fatty liver (MESH:D005234), HCC (MESH:D006528), NK lymphoma (MESH:D000077428), SCID (MESH:D053632)
- **Chemicals:** hydrogen peroxide (MESH:D006861), Dulbecco's Modified Eagle Medium (-), metal (MESH:D008670), penicillin (MESH:D010406), haematoxylin (MESH:D006416), xylene (MESH:D014992), streptomycin (MESH:D013307), fatty acids (MESH:D005227), GM6001 (MESH:C078131), CO2 (MESH:D002245), Ly294002 (MESH:C085911), citric acid (MESH:D019343), CCK-8 (MESH:D012844), aflatoxin (MESH:D000348), lenvatinib (MESH:C531958), paraformaldehyde (MESH:C003043), SDS (MESH:D012967), PVDF (MESH:C024865), sorafenib (MESH:D000077157), TAPI-1 (MESH:C092152), DAPI (MESH:C007293)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]
- **Cell lines:** NK-92 — Homo sapiens (Human), Natural killer cell lymphoblastic leukemia/lymphoma, Cancer cell line (CVCL_2142), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), Bel7402 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_5492), HLE — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_1281), HuH-7 — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_0336), sMICA/B — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_B2MD), -8 — Xenopus laevis (African clawed frog), Spontaneously immortalized cell line (CVCL_4564), 3C — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_1098)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945705/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945705/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945705/full.md

---
Source: https://tomesphere.com/paper/PMC12945705